PLS sir, may we have some more...
1H23 RESULT
Need To Know
- In-line result, production guidance upgraded (in-line with market).
- Maiden dividend of 11cps announced, fully franked.
- Re-iterate our Hold rating.
Result Highlights
Revenue: A$2.18bn, in-line with market.
EBITDA A$1.81bn, 5% beat on market.
NPAT: 1.24bn, 3% miss on market.
EPS: 41cps, 5% below market expectations.
DPS 11 cps, fully franked. The First dividend for PLS.
Guidance Upgrade
The spodumene production range was upgraded to 600-620ktpa at A$580-610/dmt. This upgrade is broadly in line with the market.
CAPEX has also been adjusted, increasing to A$445-465m. We note that the P680 spend is lower (due to the timing of spend and scheduling) but sustaining capex has more than doubled. Indicating a large increase in the second half of FY23.
Investment View
Overall, an in-line result.
The presentation indicated that lithium hydroxide pricing in January was equivalent to PLS’s last auction, at ~US$7,500/t for 5.5% Li20 product. Since then, Lithium hydroxide has fallen potentially greater than 15% suggesting that PLS may see some elevated negative provisional pricing adjustments for 3Q FY23.
The introduction of a dividend is to be well received. The dividend is a 20% payout ratio (30% when including tax payable) of the 1H FY23 free cash flow (FCF). This is consistent with the target 20-30% FCF range that the management team provided in December.
Whilst the result demonstrates some decent 1H operations, we are in the view that headline prices for spodumene will continue to fall, and the growth profile may become increasingly difficult to meet for PLS.
We re-iterate our hold rating for PLS.
Stock Overview
Share Price
Company Overview
PLS is an Australia-based pure-play lithium company. The company is primarily engaged in the exploration, development and mining of minerals in Western Australia
Disclaimers and Disclosures
Issuer
The information and opinions contained within Sandstone Insights Research were prepared by MST Financial Services Pty Ltd (ABN 54 617 475 180, AFSL 500557) ("MST").
Reliance
Whilst MST make every effort to use reliable, comprehensive information in the construction of its reports, MST make no representation, warranty or undertaking of the accuracy, timeliness or completeness of information in this report. Save for any statutory liability that cannot be excluded, MST and MST employees, representative and agents shall not be liable (whether in negligence or otherwise) for any error or inaccuracy in, or omission from, this advice or any resulting loss suffered by the recipient or any other person.
General Advice
Any advice contained within Sandstone Insights Research is general advice only and has been prepared without taking into account any person’s objectives, financial situation or needs. Any person, before acting on any advice contained within Sandstone Insights Research, should first consider consulting with a financial adviser to assess whether that advice is appropriate for their objectives, financial situation and needs.
General Disclosures
This report should be read in conjunction with MST Disclaimers and Disclosures and is published in accordance with MST Conflict Management Policy which are available on the MST website: https://www.sandstoneinsights.com.au.
Currency of Research
The recommendations made in a Sandstone Insights Research report are current as of the publication date. If you are reading a report materially after publication, it is likely that circumstances will have changed and at least some aspects of the analysis may no longer hold.
Access and Use
Any access to or use of Sandstone Insights Research is subject to the Terms of Use. By accessing or using Sandstone Insights Research you hereby agree to be bound by our Terms and Conditions and hereby liable for any monies due in payment of accessing this service. In addition you consent to us collecting and using your personal data (including cookies) in accordance with MST Privacy Policy, including for the purpose of a) setting your preferences and b) collecting readership data so MST may deliver an improved and personalised service to you. If you do not agree to MST Terms of Use and/or if you do not wish to consent to MST use of your personal data, please do not access this service.
Equities Research Methodology
Please click here for information about MST equities research methodology.